Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Other Operating Expenses (2024 - 2025)

NeuroPace (NPCE) has 2 years of Other Operating Expenses data on record, last reported at $10.9 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 63.23% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $46.6 million, up 17.42%, while the annual FY2025 figure was $46.6 million, 17.42% up from the prior year.
  • Other Operating Expenses reached $10.9 million in Q4 2025 per NPCE's latest filing, down from $23.6 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $29.7 million in Q4 2024 and bottomed at $9.9 million in Q3 2024.